Here Are the 2 Most Important Things to Look for in Novavax's Earnings Report Next Week

Here Are the 2 Most Important Things to Look for in Novavax's Earnings Report Next Week
Adria Cimino, The Motley Fool
·4 min read

Novavax doesn't have products on the market yet, which means the biotech company is yet to report an annual profit. Novavax recently reported U.K. phase 3 trial results and just completed enrollment in a U.S. phase 3 trial. Possible regulatory authorizations sit on the horizon.